✦Canada Post Xpress1–2 day delivery across CanadaFree on orders over $200
Your cart is empty
Amylin Receptor Research Peptide
Cagrilintide is a long-acting amylin analogue studied in laboratory research for its interaction with metabolic signaling pathways. Researchers investigate how it influences biochemical systems involved in nutrient regulation, satiety signaling, and glucose-related metabolic processes. It is commonly used in experimental studies exploring peptide activity in metabolic pathway research.
This product is intended strictly for laboratory research use within Canada. It is not approved by Health Canada for the diagnosis, treatment, cure, or prevention of any disease. Not for human or veterinary use.
By purchasing, you confirm the material will be used solely for lawful research purposes in accordance with applicable Canadian regulations.
Cagrilintide is a synthetic peptide developed for controlled laboratory research involving amylin receptor signaling systems. It is structurally designed to interact with amylin-associated pathways within experimental environments.
In scientific literature, cagrilintide is studied in models examining receptor-mediated signaling cascades, metabolic pathway interaction, and downstream cellular response systems under in vitro and preclinical research conditions.
Third-party tested for purity, ID, quantity.
Cagrilintide is a long-acting synthetic amylin analogue evaluated in research focused on amylin receptor activity and associated signaling pathways. Experimental studies examine receptor interaction models, endocrine-related signaling systems, and pathway-level regulatory mechanisms.
Preclinical and clinical research publications have explored its receptor-binding characteristics and downstream signaling behavior within controlled study environments.
Cagrilintide was developed through research efforts aimed at modifying native amylin analogues to extend receptor interaction duration and signaling stability. Investigations into amylin pathway modulation led to the synthesis of long-acting peptide analogues for experimental evaluation.
Subsequent research publications documented its receptor-binding profile and signaling activity within laboratory and clinical research frameworks.
Laboratory investigations into cagrilintide have focused on amylin receptor interaction models and downstream signaling pathways. Research frameworks evaluate receptor activation dynamics, endocrine-related regulatory systems, and metabolic signaling environments under controlled in vitro and preclinical conditions.
No. Eppix Labs products are supplied exclusively for laboratory research. We do not provide dosing, administration, or usage guidance.
Each vial contains 5mg of lyophilized cagrilintide. Independent third-party testing verifies purity, identity, and net content per batch.
The vial contains only the lyophilized peptide. Any laboratory materials required for experimental procedures must be sourced separately.
Duration depends entirely on research protocol, storage conditions, and laboratory application.
Related
Studied in metabolic research for its effects on glucose regulation, appetite signaling, and energy balance.
From$180.00
Dual incretin receptor agonist studied for glucose regulation, metabolic signaling, and weight pathway research
From$10.00
Immune-modulating peptide studied for T-cell signaling and immune system regulatory pathway research
From$70.00
GHRH analog studied for growth hormone regulation and metabolic pathway signaling research
From$95.00
